Saito, M. et al. 2016. Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK). Acta Oncologica. 55, 3 (Mar. 2016), 309–317. DOI:https://doi.org/10.3109/0284186X.2015.1107189.